| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 03/29/2005 | US6872714 Methods to modulate conditions mediated by the CXCR4 receptor |
| 03/29/2005 | US6872709 Using glycyrrhizin |
| 03/29/2005 | US6872707 Prevention, therapy of bacteria infections |
| 03/29/2005 | US6872701 Glycopeptide phosphonate derivatives |
| 03/29/2005 | US6872407 Extended release formulations of erythromycin derivatives |
| 03/29/2005 | US6872399 Dermatomycosis vaccine |
| 03/29/2005 | US6872395 Viruses comprising mutant ion channel protein |
| 03/29/2005 | US6872386 Immunization of aquatic animals against infectious diseases |
| 03/29/2005 | CA2425745C Expression of exogenous polynucleotide sequences in a vertebrate |
| 03/29/2005 | CA2240541C Stabilisers for live vaccines |
| 03/29/2005 | CA2180950C Kallikrein-inhibiting "kunitz domain" proteins and analogues thereof |
| 03/29/2005 | CA2049287C Expression of exogenous polynucleotide sequences in a vertebrate |
| 03/24/2005 | WO2005026333A1 Technique for suspension culture of adhesive cells using protease and method of producing virus with the use of the cells as host |
| 03/24/2005 | WO2005026186A1 Β-l-nucleosides and use thereof as pharmaceutical agents for treating viral diseases |
| 03/24/2005 | WO2005026171A1 Substance which exhibits antiviral and antibacterial activity and is based on derivatives of 2,8-dithioxo-1h-pyrano[2,3d¸6,5-d']dipyrimidyne and 10-aza-analogue thereof |
| 03/24/2005 | WO2005026165A1 Quinolone antibacterial agents |
| 03/24/2005 | WO2005026162A1 Gyrase inhibitors |
| 03/24/2005 | WO2005026161A1 Antibacterial agents |
| 03/24/2005 | WO2005026154A1 Quinolone antibacterial agents |
| 03/24/2005 | WO2005026153A1 Quinazoline-2, 4-diones as antibacterial agents |
| 03/24/2005 | WO2005026149A1 Pyrrol derivatives with antibacterial activity |
| 03/24/2005 | WO2005026147A1 7-(4-substituted 3- cyclopropylaminomethyl-1 pyrrolidinyl) quinolonecarboxylic acid derivative |
| 03/24/2005 | WO2005026146A1 Azetidinyl quinolones as antibacterial agents |
| 03/24/2005 | WO2005026145A2 Quinolone antibacterial agents |
| 03/24/2005 | WO2005026133A1 Isoxazoles as peptide deformylase inhibitors |
| 03/24/2005 | WO2005026132A1 cAMP-SPECIFIC PHOSPHODIESTERASE INHIBITOR |
| 03/24/2005 | WO2005026114A1 Hiv protease inhibitors, compositions containing the same and their pharmaceutical uses |
| 03/24/2005 | WO2005025629A1 Cyanoacrylate monomer formulation containing diiodomethyl-p-tolylsulfone |
| 03/24/2005 | WO2005025599A1 A glycopeptide composition with improved antibiotic activity |
| 03/24/2005 | WO2005025598A1 Antibacterial drug for propionibacterium acnes |
| 03/24/2005 | WO2005025585A1 Use of gentiana lutea extracts as an antimicrobial agent |
| 03/24/2005 | WO2005025583A2 Tlr7 ligands for the treatment of hepatitis c |
| 03/24/2005 | WO2005025582A1 Antibacterial compositions of n-acetyl-d-aminoglycosamine and antibiotics |
| 03/24/2005 | WO2005025574A2 PTERIDINE DERIVATIVES FOR THE TREATMENT OF SEPTIC SHOCK AND TNF-α-RELATED DISEASES. |
| 03/24/2005 | WO2005025565A1 Microbicide composition comprising a minor groove binder optionally in combination with an anti-hiv compound and use thereof in the prevention of sexually transmitted diseases |
| 03/24/2005 | WO2005025552A2 Protein binding compounds |
| 03/24/2005 | WO2005025487A2 Oligonucleotides targeting prion diseases |
| 03/24/2005 | WO2005025306A1 Compositions for feeding bees exhibiting an acaricide effect |
| 03/24/2005 | WO2005007141A3 Ubiquitin ligase inhibitors and methods related thereto |
| 03/24/2005 | WO2005005456A3 Peptide deformylase inhibitors |
| 03/24/2005 | WO2005004789A3 Method for treating diseases associated with changes of qualitative and/ quantitative composition of blood extracellular dna |
| 03/24/2005 | WO2005000348A3 Vaccines inducing nkt-cell and toll-like-receptor activation |
| 03/24/2005 | WO2005000324A3 Colloidal silver composition having antimicrobial properties |
| 03/24/2005 | WO2005000308A3 Methods of identifying hcv ns5b polymerase inhibitors and use against hepatitis c |
| 03/24/2005 | WO2004096195A3 Use of ppar-gamma agonists as anti-infective agents |
| 03/24/2005 | WO2004084645A3 Use of allicin as preservative, as disinfectant, as antimicrobial or as biocidal agent |
| 03/24/2005 | WO2003099217A3 Methods of treating bacterial infections and diseases associated therewith |
| 03/24/2005 | WO2003090687A9 Using heat shock proteins to increase immune response |
| 03/24/2005 | WO2002092759A9 Molecules for disease detection and treatment |
| 03/24/2005 | US20050065321 Cytokine receptor (Zcytor16) for use as tool in prevention and treatment of cell proliferative and nervous system disorders |
| 03/24/2005 | US20050065320 Mutated env gene, mutated env glycoprotein and the use thereof |
| 03/24/2005 | US20050065216 Therapy for multiple sclerosis, psoriasis, urticaria; antiarthritic agents; incotinence; antitumor, anticancer agents |
| 03/24/2005 | US20050065201 Fungicides in human, animals; controlling plant diseases; reacting 1-(2,4-dichlorophenyl)-2-imidazol-1-yl-ethanol with halogen substituted benzthiophene compoundu |
| 03/24/2005 | US20050065195 Oxadiazolyl-biphenylcarboxamides and their use as p38 kinase inhibitors |
| 03/24/2005 | US20050065187 Novel antimicrobial aryloxazolidinone compounds |
| 03/24/2005 | US20050065160 for the treatment and/or prophylaxis of diseases, in particular for use as antiviral agents, in particular against cytomegalo viruses |
| 03/24/2005 | US20050065148 Dipeptidyl peptidase inhibitors |
| 03/24/2005 | US20050065114 Antitumor, anticancer agents; viricides; bactericides; fungicides; immunology stimulants |
| 03/24/2005 | US20050065113 Starch derivatives, starch active substance conjugates, method for the production thereof and their use as medicaments |
| 03/24/2005 | US20050065110 Synergistic mixture; antioxidant; cardiovascular disorders; antidiabetic agents |
| 03/24/2005 | US20050065101 Halogenation with a diphenylhalosulfonimide, deblocking the protected hydroxyl group; optional esterification or addition salt formation |
| 03/24/2005 | US20050065095 Antibacterial agents |
| 03/24/2005 | US20050065093 Inhibitors of the ICE/ced-3 family of cysteine proteases |
| 03/24/2005 | US20050065075 Viricides; respiratory synctia virus; parainfluenza virus; simian immunodeficiency virus; complexing drug to blood component; immobilization; storage stability |
| 03/24/2005 | US20050065073 Aza-peptide macrocyclic hepatitis C serine protease inhibitors |
| 03/24/2005 | US20050064594 Transgenic liver cell for use as tool in diagnosis, prevention and treatment of viral diseases; viricides and receptor binding activity |
| 03/24/2005 | US20050064593 Expression vector comprising breast cancer gene (BCL-2) nucleotide sequences for use as tool in treatment, diagnosis and prevention of cell proliferative disorders |
| 03/24/2005 | US20050064586 Somatic cell derived embryonic stem cells and its differentiated cells |
| 03/24/2005 | US20050064558 Chimeric polypeptide comprising functional differentially spliced interleukin receptor and b-cell differentiation factor for enhancing expression of interferon inducible protein (IP-10) and macrophage inflammarory proteins for use in treatment of viral diseases |
| 03/24/2005 | US20050064546 Production of recombinant lactoferrin and lactoferrin polypeptides using cDNA sequences in various organisms |
| 03/24/2005 | US20050064534 Using microscopic systems to monitoring f-actin and myosin activity in cells; monitoring biopolymer transfer between membrane walls |
| 03/24/2005 | US20050064527 Identifying modulator of activity of newly identified multiple antibiotic resistance (mar) locus regulated (NIMR) gene products; microbiocides; bactericides |
| 03/24/2005 | US20050064458 Nucleotide sequences coding membrane protein for use in diagnosis, prevention and treatnment of cell proliferative, nervous system, metabolic and inflammatory disorders |
| 03/24/2005 | US20050064409 Chp for use as marker for sepsis-type inflammatory diseases |
| 03/24/2005 | US20050064396 Cellular regulators of infectious agents and methods of use |
| 03/24/2005 | US20050064032 Dosage form, device, and methods of treatment |
| 03/24/2005 | US20050064027 Prolonged gastric retention time due to bioadhesion (which may be polymers, metal oxides, or ligands for specific mucosal components); macrospheres for delivery of acyclovir for example |
| 03/24/2005 | US20050064014 Use of cystathionine |
| 03/24/2005 | US20050063993 For treatment of cancer/tumors/fungal/viral infections; tumor associated antigens; genetic engineering |
| 03/24/2005 | US20050063986 Process for the preparation of non-toxic anthrax vaccine |
| 03/24/2005 | US20050063985 Method and compositions for immunization with the pseudomonas v antigen |
| 03/24/2005 | US20050063984 Antigenic peptide fragments of vapa protein, and uses thereof |
| 03/24/2005 | US20050063958 Ex vivo gene therapy for HIV; formulation of CD34+ hematopoietic cells transduced with a viral construct which expresses an anti-HIV agent such as a ribozyme |
| 03/24/2005 | US20050063957 Antibacterial therapy with bacteriophage genotypically modified to delay inactivation by the host defense system |
| 03/24/2005 | US20050063954 Recombinant reovirus for treating a Ras-mediated proliferative disorder such as tumors |
| 03/24/2005 | US20050063949 Method of treating hepatitis virus infection with a multiphasic interferon delivery profile |
| 03/24/2005 | US20050063943 Conjugated of hydroxyalkyl starch and an active agent |
| 03/24/2005 | US20050063907 Radioopaque sustained release pharmaceutical system |
| 03/24/2005 | US20050063905 Administering a RADIONUCLIDE COMPLEXED WITH A CHELATING AGENT SUCH AS MACROCYCLIC AMINOPHOSPHONIC ACID, or tetraazacyclododecanetetramethylenephosphonic acid (DOTMP); polycythemia vera, macroglobulinemia (Waldenstrom syndrome), megakaryocytic myelosis, malignant histiocytosis |
| 03/24/2005 | DE102004042021A1 Use of chitin, chitosan or their derivatives for prophylactic and therapeutic purposes in agricultural livestock production |
| 03/24/2005 | CA2539160A1 Antibacterial agents |
| 03/24/2005 | CA2538552A1 Pyrrol derivatives with antibacterial activity |
| 03/24/2005 | CA2538429A1 Antibacterial drug for propionibacterium acnes |
| 03/24/2005 | CA2538420A1 Quinolone antibacterial agents |
| 03/24/2005 | CA2538245A1 Oligonucleotides targeting prion diseases |
| 03/24/2005 | CA2537860A1 Gyrase inhibitors |
| 03/24/2005 | CA2482232A1 Protease inhibitor conjugates and antibodies useful in immunoassay |
| 03/23/2005 | EP1516932A1 Poxvirus with targeted infection specificity |
| 03/23/2005 | EP1516873A1 2-pyridinone derivatives, having HIV inhibiting properties |
| 03/23/2005 | EP1516626A1 A Teicoplanin composition with improved antibiotic activity |